Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Polycystins Expression in Astrocytic Gliomas

View through CrossRef
Background: Polycystin 1 (PC1) and polycystin 2 (PC2) proteins are members of the transient receptor potential (TRP) channels family and are encoded from PKD1 and PKD2 genes, respectively. Until recently, the role of PKD1 and PKD2 has been associated with the pathogenesis of the kidney since mutations in these genes cause autosomal dominant polycystic kidney disease (ADPKD). Recent data implicates polycystins in the pathogenesis of solid tumors. In this aspect, the expression of PKD1 and PKD2 in human astrocytomas is largely unknown. The aim of the present research study was to investigate the expression of PKD1 and PKD2 in astrocytic tumors and correlate it with clinicopathological characteristics such as the grade of malignancy, age, and gender of the patients. Methods: A total of 70 cases—corresponding to 8 grade II (diffuse fibrillary astrocytomas), 12 grade III (anaplastic astrocytomas), and 50 grade IV (glioblastomas multiforme)—were examined. The mRNA expression levels of PKD1 and PKD2 were determined through molecular qRT-PCR analysis using the relative quantification ΔΔCt method and the expression of PC1 and PC2 was detected through immunohistochemistry using the semi-quantitative H-score system. Results: Increased levels of PKD1 and PKD2 in astrocytomas were found compared with that of a normal brain (p < 0.05). Glioblastomas demonstrated the greatest increase in PKD1 and PKD2 expression compared to other grades of malignancy (p < 0.05). The same pattern of expression showed PC1 and PC2 proteins. A significant correlation between PKD1 and PKD2 as well as PC1 and PC2 expressions was found (p < 0.05). Although no association was detected between PC1 or PC2 and Ki67 expression (p > 0.05), a significant correlation between PC1 and p53 immunoexpressions, in grade III and between PC2 and p53 immunoexpressions, in grade II astrocytomas (p < 0.01) has emerged. PC1 expression was correlated with age of the patients (p < 0.05). PKD1 and PKD2 expression were negatively correlated with the prognosis of glioma patients. Conclusions: The results of this study indicate the potential involvement of polycystins in the pathogenesis of astrocytomas. However, further research is required to fully understand the mechanisms that these molecules are implicated.
Title: Polycystins Expression in Astrocytic Gliomas
Description:
Background: Polycystin 1 (PC1) and polycystin 2 (PC2) proteins are members of the transient receptor potential (TRP) channels family and are encoded from PKD1 and PKD2 genes, respectively.
Until recently, the role of PKD1 and PKD2 has been associated with the pathogenesis of the kidney since mutations in these genes cause autosomal dominant polycystic kidney disease (ADPKD).
Recent data implicates polycystins in the pathogenesis of solid tumors.
In this aspect, the expression of PKD1 and PKD2 in human astrocytomas is largely unknown.
The aim of the present research study was to investigate the expression of PKD1 and PKD2 in astrocytic tumors and correlate it with clinicopathological characteristics such as the grade of malignancy, age, and gender of the patients.
Methods: A total of 70 cases—corresponding to 8 grade II (diffuse fibrillary astrocytomas), 12 grade III (anaplastic astrocytomas), and 50 grade IV (glioblastomas multiforme)—were examined.
The mRNA expression levels of PKD1 and PKD2 were determined through molecular qRT-PCR analysis using the relative quantification ΔΔCt method and the expression of PC1 and PC2 was detected through immunohistochemistry using the semi-quantitative H-score system.
Results: Increased levels of PKD1 and PKD2 in astrocytomas were found compared with that of a normal brain (p < 0.
05).
Glioblastomas demonstrated the greatest increase in PKD1 and PKD2 expression compared to other grades of malignancy (p < 0.
05).
The same pattern of expression showed PC1 and PC2 proteins.
A significant correlation between PKD1 and PKD2 as well as PC1 and PC2 expressions was found (p < 0.
05).
Although no association was detected between PC1 or PC2 and Ki67 expression (p > 0.
05), a significant correlation between PC1 and p53 immunoexpressions, in grade III and between PC2 and p53 immunoexpressions, in grade II astrocytomas (p < 0.
01) has emerged.
PC1 expression was correlated with age of the patients (p < 0.
05).
PKD1 and PKD2 expression were negatively correlated with the prognosis of glioma patients.
Conclusions: The results of this study indicate the potential involvement of polycystins in the pathogenesis of astrocytomas.
However, further research is required to fully understand the mechanisms that these molecules are implicated.

Related Results

Abstract 4113: A multimodal (PET/NIRF) smart probe for selectively identifying, grading, and visualizing astrocytic gliomas
Abstract 4113: A multimodal (PET/NIRF) smart probe for selectively identifying, grading, and visualizing astrocytic gliomas
Abstract Astrocytic gliomas are the most common glioma subtype and constitute the majority of all primary brain tumor types. The malignancy of an astrocytic glioma i...
Inspiration and inflammation in the breathing brainstem
Inspiration and inflammation in the breathing brainstem
<p dir="ltr">Neonatal breathing is highly vulnerable to disturbances, and conditions such as respiratory distress syndrome, apnea, and Sudden Unexpected Postnatal Collapse (S...
Inspiration and inflammation in the breathing brainstem
Inspiration and inflammation in the breathing brainstem
<p dir="ltr">Neonatal breathing is highly vulnerable to disturbances, and conditions such as respiratory distress syndrome, apnea, and Sudden Unexpected Postnatal Collapse (S...
Decreased Expression of PACSIN1 in Brain Glioma Samples Predicts Poor Prognosis
Decreased Expression of PACSIN1 in Brain Glioma Samples Predicts Poor Prognosis
Gliomas are the most severe brain tumours with a poor prognosis. Although surgery, postoperative radiotherapy and chemotherapy can improve the survival rate of glioma patients, the...
Expression of Anaplastic Lymphoma Kinase in Astrocytic Tumors (Histopathological and Immunohistochemical Study)
Expression of Anaplastic Lymphoma Kinase in Astrocytic Tumors (Histopathological and Immunohistochemical Study)
BACKGROUND: Astrocytic tumors are the most common primary brain tumors. Glioblastoma is the most common astrocytic tumor representing the highest World Health Organization (WHO) gr...
68Ga-PSMA-11 PET/CT Imaging in Brain Gliomas and Its Correlation With Clinicopathological Prognostic Parameters
68Ga-PSMA-11 PET/CT Imaging in Brain Gliomas and Its Correlation With Clinicopathological Prognostic Parameters
Background Gliomas are the most common primary central nervous system tumors, of which the malignant gliomas account for 60%–75%. The primary and secondary brain malign...
Abstract 1345: Mutant IDH1 and tissue factor in gliomas
Abstract 1345: Mutant IDH1 and tissue factor in gliomas
Abstract Background: IDH1 mutations (IDH1mut) occur in 20-30% of gliomas, induce DNA hypermethylation, and are associated with a better prognosis than IDH1 wild-type...

Back to Top